VC Deals Analysis: Asia Investors Pour Money Into Grail And May's Other Big Deals

Asian investors' unrelenting pursuit of medtech ventures continued to crescendo in May. The participants in the largest round so far this year, the $300m series C by Illumina spin-out Grail, are all China-based funds.